Molecular Therapy, Volume 20, Issue 12, Pages 2191-2370

Oligonucleotide Therapy

Buffering Capacity and Size of siRNA Polyplexes InfluenceCytokine Levels

Qixin Leng, Szu-Ting Chou, Puthupparampil V Scaria, Martin C Woodle and A James Mixson

Mol Ther 20: 2282-2290; advance online publication, October 2, 2012; doi:10.1038/mt.2012.206

Nonviral Delivery of Small Interfering RNA IntoPancreas-associated Immune Cells Prevents Autoimmune Diabetes

Wilhem Leconet, Pierre Petit, Sylvie Peraldi-Roux and Damien Bresson

Mol Ther 20: 2315-2325; advance online publication, September 18, 2012; doi:10.1038/mt.2012.190

Clinical Trials

Mesenchymal Stromal Cells Treatment Attenuates Dry Eye inPatients With Chronic Graft-versus-host Disease

Jianyu Weng, Chang He, Peilong Lai, Chenwei Luo, Rong Guo, Suijing Wu, Suxia Geng, Andy Xiangpeng, Xialin Liu and Xin Du

Mol Ther 20: 2347-2354; advance online publication, October 16, 2012; doi:10.1038/mt.2012.208